VA-ECMO Support in Heart Transplantation
Author Information
Author(s): Giovannico Lorenzo, Fischetti Giuseppe, Parigino Domenico, Savino Luca, Di Bari Nicola, Milano Aldo Domenico, Padalino Massimo, Bottio Tomaso
Primary Institution: University of Bari Aldo Moro, Bari, Italy
Hypothesis
How does veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support affect outcomes in heart transplantation?
Conclusion
VA-ECMO is crucial for managing primary graft dysfunction in heart transplant patients, improving survival rates and reducing complications.
Supporting Evidence
- Heart transplantation is the gold standard for end-stage heart failure.
- Primary graft dysfunction is a leading cause of death within 30 days post-transplant.
- VA-ECMO provides effective treatment for severe primary graft dysfunction.
Takeaway
VA-ECMO helps patients who have heart transplants by keeping their new heart working well and giving it time to heal.
Methodology
This is a review of existing literature on the use of VA-ECMO in heart transplantation.
Limitations
The review is based on existing studies, which may have varying methodologies and sample sizes.
Participant Demographics
The review discusses heart transplant candidates, including elderly patients and those with multiple comorbidities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website